A New Opportunity

Through identifying a sizeable gap in the market for fillers to maximise volume, suppleness and longevity combined, MaiLi utilised a unique opportunity to design a premium line of HA gels to meet this demand.

Model is not an actual patient.

After my treatment with MaiLi, I felt it gave my appearance a boost. The natural looking results are amazing. - Amira - MaiLi client

MaiLi’s Projection Force Was Tested Against Competitors

MaiLi’s Leading Edge

The graph demonstrates the exceptional potential of MaiLi’s portfolio vs Juvéderm’s® marketleading range, with MaiLi Extreme’s propensity to achieve maximum volume and projection power over Juvéderm® Volux – while maintaining extreme suppleness and elasticity.

MaiLi Extreme vs Juvéderm® Voluma

The volumising capacity of MaiLi Extreme vs Juvéderm® Voluma was assessed by a skin model assay – a reliable and reproducible in vitro model using artificial skin to evaluate the projection capacity of HA fillers. Here, MaiLi Extreme is verified as one of the most volumising and supple fillers available, with an unparalleled projection rate of 34%* against Juvéderm® Voluma.

MaiLi Extreme vs Juvéderm® Voluma

Step One Deposit of the tested HA gels Step Two HA gels are overlaid by the upper skin layer Step Three Measurement of the projection height induced by each gel

MaiLi Extreme vs Juvéderm® Volux

With outstanding volume and suppleness combined, MaiLi Extreme continues to outperform Juvederm even with their most volumising filler – Juvéderm® Volux – with an elevated projection rate of +17%.***

MaiLi Extreme vs Juvéderm® Volux

Step One Deposit of the tested HA gels Step Two HA gels are overlaid by the upper skin layer Step Three Measurement of the projection height induced by each gel

MaiLi Extreme vs Juvéderm® Voluma

This graph demonstrates MaiLi Extreme’s ability to use 24% less gel for the same volumising results as Juvéderm® Voluma. Not only does less product mean more treatment possibilities for patients, but practitioners can use the same syringe in multiple areas to exceed patient results. Results which gradually build over time, with better results achieved in less visits.

MaiLi Extreme vs Juvéderm® Voluma

Across all time points more patients*** reported an exceptional improvement in volume for MaiLi Extreme compared with Juvéderm® Voluma.

Get started with MaiLi

An Unstoppable Portfolio

12-Month Results

MaiLi’s entire portfolio continues to show high-performing results at 12 months – including exceptional longevity in lip treatments. Significant improvement in GAIS was still visible at 12 months – with 81% of treated patients showing improved, very improved or exceptionally improved results in that period – with no top-up treatment performed.

12-Month Results

With no top-ups within the year, improvements are still noticeable for 100% of treated indications*** – further demonstrating the endless potential of MaiLi for practitioners to elevate their results and reputation.

Results That Last

The graph demonstrates MaiLi Define’s superior results in Lip treatment, with effects still visible after 12 months***.

MaiLi's Portfolio

Reverse the Signs of Ageing

Quality

Craft your cosmetic vision with a premium gel offering supple volume, projection power and elasticity – reflecting natural movement for authentic beauty.

Efficiency

Treat areas with more fullness from less filler*, resulting in long-lasting satisfaction, that may bring positive reviews and repeat bookings.

^{*Clinical investigation 17E1176: in comparison to Juvederm® Voluma, 24% less product of MaiLi Extreme was injected for the same results in the treatment of the cheek area.}

Longevity

MaiLi’s cutting-edge science creates durable gels with market-leading results – including supple, full lips lasting up to a year.**

^{**Data on file.}^{GAIS, Global Aesthetic Improvement Scale.}

Safety

MaiLi has a good safety profile, which is why all products are developed with the utmost care, while using lidocaine for a more comfortable experience.

Get started

Contact Us

Title

First Name

Last Name

Speciality

Address 1

Address 2

Postcode

City

Country

I Accept Terms & Conditions

^{*Clinical investigation 17E1176: in comparison to Juveìderm® Voluma, 24% less product of MaiLi Extreme was injected for the same results in the treatment of the cheek area.}

^{***Data on file.}^{Group 4 in the clinical trial17E1176: 40 injections sites in 20 patients. GAIS, global aesthetic improvement scale}

^{*** Data on file.}^{GAIS, Global Aesthetic Improvement Scale.}